ArticleHypertension research : official journal of the Japanese Society of Hypertension2025
Association between urinary sodium-to-potassium ratio and BNP in a general population without antihypertensive treatment and cardiovascular diseases: the Ohasama study.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Current hypertension epidemiology and contemporary approaches using the "Real-World Evidence Cycle" framework.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Review
Corrections and comments
- Commented on by
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The urinary sodium-to-potassium (Na/K) ratio is associated with blood pressure (BP) and cardiovascular risk. We examined the association between the urinary Na/K ratio and brain natriuretic peptide (BNP), a biomarker indicative of cardiac stress levels within the general population. This cross-sectional study included 436 participants (mean age: 65.4 ± 6.9 years; 73.2% women) without antihypertensive medications or cardiovascular diseases (including atrial fibrillation) from the Ohasama Study. The urinary Na/K ratio was calculated using casual daytime spot urine samples. Analyses of covariance and multiple linear and Poisson regression models were conducted. The median BNP value was 18.6 pg/mL (interquartile range: 11.4-31.2 pg/mL). Participants in the first (≤2.19), second (2.19-3.27), and third (≥3.28) tertiles of the urinary Na/K ratio had adjusted mean natural log-transformed (ln)BNP of 2.74, 2.88, and 3.06 (converted BNP values: 15.50, 17.81, and 21.37 pg/mL), respectively, after adjusting for covariates including estimated glomerular filtration rate, home systolic BP, and Sokolow-Lyon voltage (P for trend = 0.0005). The adjusted prevalence ratios (95% confidence intervals) for BNP ≥35 pg/mL were 1.27 (0.76-2.14) and 2.24 (1.35-3.72) in the second and third tertiles, respectively, compared with the lowest tertile. The highest standardized regression coefficient for lnBNP was observed for the urinary Na/K ratio ( | 0.24 | ), surpassing estimated 24-h urinary sodium ( | 0.16 | ) or potassium ( | 0.09 | ) excretion. In conclusion, urinary Na/K ratio was associated with elevated BNP levels in individuals without antihypertensive treatment and cardiovascular disease history. This urinary marker may be valuable for early prevention of organ damage and cardiac burden.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.